| 000 | 01715ngm a2200409 a 4500 | ||
|---|---|---|---|
| 001 | HST4455 | ||
| 003 | UkLoHST | ||
| 006 | m c | ||
| 007 | cr|cna|||a|||| | ||
| 007 | vz|czazum | ||
| 008 | 170821s2017 enk|||||||||||s|||v|eng d | ||
| 028 | 5 | 0 |
_a4455 _bHenry Stewart Talks |
| 035 | _a(UkLoHST)3545 | ||
| 040 |
_aUkLoHST _beng _cUkLoHST |
||
| 100 | 1 |
_aGreten, Tim, _u(Bethesda, USA) _4spk |
|
| 245 | 1 | 0 |
_aImmunotherapy of hepatocellular carcinoma _h[electronic resource] / _cTim Greten. |
| 260 |
_aLondon : _bHenry Stewart Talks, _c2017. |
||
| 300 |
_a1 online resource (1 streaming video file (43 min.) : _bcolor, sound). |
||
| 490 | 1 |
_aImmunotherapy of cancer, _x2056-452X |
|
| 500 | _aAnimated audio-visual presentation with synchronized narration. | ||
| 500 | _aTitle from title frames. | ||
| 505 | 0 | _aContents: Hepatocellular carcinoma (HCC) background and overview -- Non-alcoholic steatohepatitis (NASH) and HCC -- Immune suppressor mechanisms in tumour environments -- Ongoing and future immunotherapy trials in HCC. | |
| 506 | _aAccess restricted to subscribers. | ||
| 538 | _aMode of access: World Wide Web. | ||
| 650 | 0 |
_aCancer _xImmunotherapy. |
|
| 650 | 0 |
_aLiver _xCancer. |
|
| 650 | 2 |
_aCarcinoma, Hepatocellular _ximmunology. |
|
| 650 | 2 |
_aCarcinoma, Hepatocellular _xtherapy. |
|
| 650 | 2 | _aImmunosuppression. | |
| 650 | 2 | _aImmunotherapy. | |
| 650 | 2 |
_aLiver Neoplasms _ximmunology. |
|
| 650 | 2 |
_aLiver Neoplasms _xtherapy. |
|
| 650 | 2 | _aNon-alcoholic Fatty Liver Disease. | |
| 830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pImmunotherapy of cancer. |
|
| 856 | 4 | 0 | _uhttps://hstalks.com/bs/3545/ |
| 856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/896/ _3Series |
| 999 |
_c76484 _d76484 |
||